Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.71 USD | -2.34% | -5.49% | -45.96% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.96% | 705M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.02% | 22.27B | |
-12.64% | 22.22B | |
-5.24% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Sage Therapeutics, Inc., Q3 2023 Earnings Call, Nov 07, 2023